Electrophoretic purification of tumor-targeted polyethylenimine-based polyplexes reduces toxic side effects in vivo
- 8 October 2007
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 122 (3) , 236-245
- https://doi.org/10.1016/j.jconrel.2007.05.013
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- DNA polyplexes based on degradable oligoethylenimine-derivatives: Combination with EGF receptor targeting and endosomal release functionsJournal of Controlled Release, 2006
- Melittin analogs with high lytic activity at endosomal pH enhance transfection with purified targeted PEI polyplexesJournal of Controlled Release, 2006
- PEGylation of Poly(ethylene imine) Affects Stability of Complexes with Plasmid DNA under in Vivo Conditions in a Dose-Dependent Manner after Intravenous Injection into MiceBioconjugate Chemistry, 2005
- Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transferThe Journal of Gene Medicine, 2004
- Genuine DNA/polyethylenimine (PEI) Complexes Improve Transfection Properties and Cell SurvivalJournal of Drug Targeting, 2004
- In situ single cell observation by fluorescence resonance energy transfer reveals fast intra‐cytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethylenimineThe Journal of Gene Medicine, 2004
- PEI – a potent, but not harmless, mucosal immuno-stimulator of mixed T-helper cell response and FasL-mediated cell death in miceGene Therapy, 2003
- Synthesis of Linear Polyethylenimine Derivatives for DNA TransfectionBioconjugate Chemistry, 2003
- Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID miceHepatology, 2002
- Side‐effects of a systemic injection of linear polyethylenimine–DNA complexesThe Journal of Gene Medicine, 2001